The Effect of Poloxamer 188 on the Solubility and Dissolution Behaviors of Piroxicam-PEG 4000 Solid Dispersions
Open Access
- 2 October 2025
- journal article
- Published by Etflin in Sciences of Pharmacy
- Vol. 4 (4) , 261-269
Abstract
Piroxicam (PRX), a non-steroidal anti-inflammatory drug (NSAID), is classified as a biopharmaceutical classification system class II (high permeability and low solubility), which limits its bioavailability. Enhancement of the dissolution rate is a key strategy to enhance the absorption. Solid dispersion systems, particularly when combined with amphiphilic multiple co-block polymers, offer a promising approach to address this challenge. This study aimed to investigate the effect of Poloxamer 188 (P188) and the solid dispersion technique on the solubility and dissolution rate of PRX. Polyethylene glycol (PEG) 4000-based solid dispersions containing PRX were prepared using varying concentrations of Poloxamer 188 surfactant through the fusion method. The solid dispersions were evaluated for saturated solubility in water for 24 hours. Selected formulations were further characterized using thermal analysis and vibrational spectroscopy. The optimized solid dispersion formulation was filled into capsules, and a dissolution assay was carried out to compare its performance with that of pure PRX capsules. The optimized formula, comprising 3% P188 and PEG4000, demonstrated a significant enhancement in saturation solubility parameters (p < 0.05), specifically the Cmax/S0 ratio. Additionally, dissolution testing showed a 22.22% increase in the dissolution rate of the PRX solid dispersion capsules compared to pure PRX capsules. In conclusion, P188-based solid dispersion containing PRX enhanced the solubility and dissolution rate, potentially improving therapeutic efficacy.Keywords
This publication has 51 references indexed in Scilit:
- Advances in the development of amorphous solid dispersions: The role of polymeric carriersAsian Journal of Pharmaceutical Sciences, 2023
- Development and validation of a simple method for the determination of Atorvastatin calcium in pure and pharmaceutical formulations using spectrofluorimetryHeliyon, 2023
- Study of a low-dose capsule filling process by dynamic and static tests for advanced process understandingInternational Journal of Pharmaceutics, 2018
- Preparation and characterization of pelletized solid dispersion of resveratrol with mesoporous silica microparticles to improve dissolution by fluid-bed coating techniquesAsian Journal of Pharmaceutical Sciences, 2016
- Physicochemical and structure-activity properties of piroxicam—a mini reviewComparative Clinical Pathology, 2016
- Current trends and future perspectives of solid dispersions containing poorly water-soluble drugsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Correlation of Inhibitory Effects of Polymers on Indomethacin Precipitation in Solution and Amorphous Solid Crystallization Based on Molecular InteractionPharmaceutical Research, 2013
- Development of a New Method to Assess Nanocrystal Dissolution Based on Light ScatteringPharmaceutical Research, 2012
- Influence of formulation and process parameters on the release characteristics of ethylcellulose sustained-release mini-matrices produced by hot-melt extrusionEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification systemEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004